Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Healthcare (Basel) ; 10(12)2022 Dec 16.
Artículo en Inglés | MEDLINE | ID: mdl-36554073

RESUMEN

BACKGROUND: The way postpartum parents' COVID-19-related concerns are associated with the family environment, support resources and depressive symptoms areunder-investigated. METHODS: Two hundred and forty-three new parents (132 mothers, 111 fathers) completed self-report questionnaires within an 8-week period after birth. Parental concerns for COVID-19-related life changes were assessed with the COVID-19 Questionnaire, perceived social support with the Multidimensional Scale of Perceived Social Support, perceived family functioning with the Family Adaptability and Cohesion Evaluation Scales IV Package, dyadic coping behaviors with the Dyadic Coping Inventory and maternal/paternal postnatal depression with the Edinburgh Postnatal Depression Scale. RESULTS: (a) Higher levels of COVID-19-related concerns about daily life were associated with lower levels of family communication, satisfaction and increased depressive symptomatology in both parents, and with lower levels of family functioning in mothers; (b) Maternal health care COVID-19-related concerns were linked with lower levels of family communication, lower perceived social support and with an increase in maternal depressive symptoms; and (c) COVID-19-related concerns about neonate hospitalization were associated with increased maternal depressive symptoms. CONCLUSION: Τhese findings suggest that COVID-19-related concerns had a common negative effect on both postpartum mothers' and fathers' mental health and on certain aspects of family functioning.

2.
J Pediatr Hematol Oncol ; 27(10): 551-3, 2005 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-16217259

RESUMEN

The authors describe a 4-year-old girl with acute lymphoblastic leukemia in remission who developed fulminant hepatic failure due to varicella-zoster virus (VZV). Diagnosing VZV visceral infection in immunocompromised patients is often difficult due to atypical clinical presentation with few or no skin lesions and severe abdominal or back pain. Prompt initiation of empirical treatment with acyclovir and VZV immunoglobulin pending results of the serum polymerase chain reaction for VZV is warranted in this clinical setting.


Asunto(s)
Varicela/virología , Hepatitis Viral Humana/virología , Herpesvirus Humano 3/aislamiento & purificación , Fallo Hepático Agudo/virología , Leucemia-Linfoma Linfoblástico de Células Precursoras/fisiopatología , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Varicela/tratamiento farmacológico , Preescolar , Resultado Fatal , Femenino , Hepatitis Viral Humana/tratamiento farmacológico , Humanos , Huésped Inmunocomprometido , Fallo Hepático Agudo/tratamiento farmacológico , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamiento farmacológico , Inducción de Remisión
3.
J Pediatr Hematol Oncol ; 27(5): 288-92, 2005 May.
Artículo en Inglés | MEDLINE | ID: mdl-15891568

RESUMEN

The authors describe a 9-year-old girl with precursor-B acute lymphoblastic leukemia (ALL) who presented with dehydration and severe hypercalcemia. She had received oral vitamin D and calcium supplementation for 4 days, the last dose 48 hours prior to admission, and required pediatric intensive care unit (PICU) hospitalization for management of the hypercalcemia and safe initiation of induction chemotherapy. Her clinical course was complicated by pancreatitis, disseminated intravascular coagulation, pleural effusion, and focal seizures. Although the exact mechanism of hypercalcemia was not elucidated, it was likely related to the underlying ALL, without dismissing the prior vitamin D and calcium supplementation as a possible contributing factor. The hypercalcemia resolved with specific antileukemic therapy along with supportive care and administration of calcitonin. Hypercalcemia is an uncommon metabolic abnormality in children with ALL, but it can be life-threatening. Children with ALL should be referred to tertiary-care institutions with PICU and subspecialty support because serious metabolic and other complications can occur before or after the administration of chemotherapy.


Asunto(s)
Linfoma de Burkitt/complicaciones , Hipercalcemia/complicaciones , Enfermedad Aguda , Calcio/administración & dosificación , Calcio/uso terapéutico , Niño , Deshidratación/complicaciones , Dexametasona/uso terapéutico , Suplementos Dietéticos , Femenino , Humanos , Hipercalcemia/tratamiento farmacológico , Hipercalcemia/etiología , Metotrexato/uso terapéutico , Pancreatitis/complicaciones , Resultado del Tratamiento , Vitamina D/administración & dosificación , Vitamina D/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA